PATENT CLAIM ANALYSIS

Application Number: 16195126
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "549000"]

Abstract:
In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dL to about 500 mg/dL, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.

Claim (Index 5):
The method of  claim 1 , wherein the subject is administered the composition daily for at least about 3 years.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 98.0
- Lexical Diversity: 1.77083
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16005969', '16006003', '16156879', '16162115', '15333968']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6137755447900404
- 35 USC 102 Novelty (BERT): 0.512281592245512
- Combined Prediction Score: 0.6036261495355875
- Mean Citation Score: 265.17639799999995
- Max Citation Score: 268.49963
- Similarity Product: 186.44848298486176

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test